...Mathias Brown Pedersen; Stefan Dukanovic; Jacob Bertram Springborg; Mikkel Andreassen; Jesper Krogh Introduction: Transsphenoidal surgery is the current treatment for mass reduction in patients with non-functional pituitary adenomas (NFPAs). The surgical procedure may deteriorate or recover...

...Congxin Dai; Yanghua Fan; Xiaohai Liu; Xinjie Bao; Yong Yao; Renzhi Wang; Ming Feng Objective: Transsphenoidal surgery (TSS) is the first-line treatment of patients with Cushing’s disease (CD). However, biochemical remission rates after TSS for CD vary from 59 to 95%, and the predictors of surgical...

...Yifan Liu; Xiaohai Liu; Xinyu Hong; Penghao Liu; Xinjie Bao; Yong Yao; Bing Xing; Yansheng Li; Yi Huang; Huijuan Zhu; Lin Lu; Renzhi Wang; Ming Feng Background: There are no reliable predictive models for recurrence after transsphenoidal surgery (TSS) for Cushing’s disease (CD). Objectives...

...Michael Buchfelder; Sven Schlaffer In this article, the present status of neurosurgical operations for Cushing’s disease is briefly reviewed. Transsphenoidal surgery is considered the treatment of choice in most patients with Cushing’s disease once the diagnosis has been established...

...Akira Sata; Naomi Hizuka; Takakazu Kawamata; Tomokatsu Hori; Kazue Takano Transient diabetes insipidus is a well-known complication after transsphenoidal surgery (TSS). On the other hand, transient hyponatremia has been reported as being a delayed complication of TSS. Transient hyponatremia has...